A Study in Participants Previously Enrolled in a Genentech- and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study (IMbrella A)
Clinical trial NCT03148418 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03148418
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-20
- Primary completion
- 2026-12-31
- Enrollment
- 382
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.